NEXTCURE INC has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are HERMAN WILLIAM, TENSIVE CONTROLS INC and LINDHOFER HORST.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 3 | |
#3 | Brazil | 3 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Republic of Korea | 3 | |
#7 | United States | 3 | |
#8 | China | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Liu Linda | 21 |
#2 | Flies Dallas Benjamin | 17 |
#3 | Langermann Solomon | 16 |
#4 | Linda Liu | 3 |
#5 | Langermann Soloman | 3 |
#6 | Solomon Langermann | 3 |
#7 | Dallas Benjamin Flies | 3 |
#8 | Flies Dallas | 3 |
#9 | Flies Benjamin Dallas | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019169229A1 | Klrg1 binding compositions and methods of use thereof | |
CA3089469A1 | B7-h4 antibodies and methods of use thereof | |
AU2017330346A1 | Antibodies for Siglec-15 and methods of use thereof | |
CA3032826A1 | Compositions and methods for modulating lair signal transduction |